APAC
Medical writing to be valued at $8.4b by 2030
Medical writing to be valued at $8.4b by 2030
The market is expanding at its quickest rate in the Asia Pacific.
1 day ago
Global colorectal cancer screening market to reach $46.1b by 2029
It is driven by rising number of colorectal cancer cases.
1 day ago
Coagulation analyser market to hit $5.34b by 2030
It is driven by aging population and rise in blood disorders
1 day ago
GE HealthCare earns double wins at Healthcare Asia Medtech Awards 2025
The company was commended for its Sonic DL™ product and initiatives that strengthen employee engagement as well as community support.
What to expect with APAC’s hospital information systems market?
Thanks to improvements in healthcare infrastructure.
APAC to see fastest growth in global medical bioreactor market
Thanks to increased healthcare spending and growing pharma capabilities.
APAC to see fastest stationary patient room pressure monitor market growth
The global market is expected to reach $810m by 2034.
ASEAN point-of-care diagnostics market to hit $1.36b by 2030
Thanks to the rising demand for regular monitoring and early detection.
Strategic brand & design: A smart prescription to drive growth in healthcare
As global brands navigate diverse markets, it becomes deeply important to design for cultural nuances.
APAC to see highest growth in the global single-cell analysis market
Thanks to a focus on cell-based therapies and high government investment.
Global medical imaging market to reach $82.6b by 2029
A key driver is the growing demand for non-invasive diagnostics.
US foreign aid cuts pressure health systems in emerging markets
At least 38% of USAID funds have been cut compared to FY 2024-25.
What’s next for the APAC oxygen concentrator market?
Emerging countries like China, Japan, and India are major contributors to growth.
Global medical devices market to reach $827.88b by 2032
The rising prevalence of chronic diseases fuels sector growth.
Advancing kidney care in Singapore to extend lives, expand possibilities for patients
Singapore’s rising prevalence of kidney disease highlights the crucial need for efficient solutions to empower patients and care teams.
APAC’s price controls, tendering processes pose risks to pharma firms
Such practices could impact revenues and market access.
APAC’s HTA adoption to grow amidst infrastructure, talent challenges
Key markets include Indonesia, the Philippines, and Australia.
Read Here
Advertise
Sign Up
Commentary
Strategic brand & design: A smart prescription to drive growth in healthcare